Cancer drugs are closing in on some of the deadliest mutations

The protein KRAS, mutated in many cancers, was deemed 'undruggable'. Now scientists are hoping to save lives with a batch of new compounds that target it. The protein KRAS, mutated in many cancers, was deemed 'undruggable'. Now scientists are hoping to save lives with a batch of new compounds that target it.

Automated summary

Scientists are aiming to save lives by targeting the mutated KRAS protein with a batch of new compounds, despite it being previously considered 'undruggable'.